Back

Antiproteinuric efficacy of ACE inhibitors, selective MRAs and ACE inhibitor/ selective MRA combination therapy in diabetic hypertensives with microalbuminuria

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Hypertension special circumstances Renin-Angiotensin System ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Mostafa El Mokadem

Faculty of Medicine - Beni Suef University, Beni Suef (Egypt)

12 More presentations in this session

Presentation thumbnail
Doctor O. Paez (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Associate Professor A. Ilic (Novi Sad, RS)
Abstract Slides
Presentation thumbnail
Assistant Professor E. Pagourelias (Thessaloniki, GR)
Abstract Slides
Presentation thumbnail
Professor M. Burnier (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Hypertension special circumstances

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage
27 August 2021
thumbnail
Congress Presentation
Successful perindopril/amlodipine+indapamide treatment as second line in uncontrolled hypertensive patients in line with european guidelines
7 April 2022
thumbnail
Congress Presentation
Mineralocorticoid receptor antagonists after acute myocardial infarction in patients with mild to moderately reduced ejection fraction
22 May 2023
thumbnail
Congress Presentation
Telmisartan versus Enalapril in heart failure with reduced ejection fraction patients with moderately impaired kidney functions; randomized controlled trial. (TRIUMF trial)
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources